While both Beam Therapeutics and Wave Life Sciences touted notable biomarker benefits for their respective alpha-1 antitrypsin deficiency assets, analysts said that Beam might have the efficacy ...
Wave Life Sciences Ltd (NASDAQ:WVE) is one of the 13 Best Revenue Growth Stocks to Buy Right Now. On February 2, Wave Life Sciences Ltd. (NASDAQ:WVE) said it regained full rights to WVE-006, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results